je.st
news
Tag: patient
AC/DC Power Supplies are rated for direct patient contact.
2016-02-15 14:31:05| Industrial Newsroom - All News for Today
Providing 200 W of power in 3 x 5 in. footprint, PMAM200 Series features 90–264 Vac input and single outputs of 12, 19, and 24 Vdc. Series is BF (Body Floating) direct patient contact rated, with Class I and II inputs, and is certified to UL/cUL/EN60601-1 3rd Edition. Operating from -40 to +70°C, medical power supplies provide >87% efficiency, no-load power consumption of <0.5 W, and MTBF of more than 100,000 hours per MIL-HDBK-217F at full load and 25°C ambient.
Tags: contact
power
direct
supplies
First confirmed Zika patient in Virginia speaks
2016-02-04 18:03:56| Biotech - Topix.net
A Harrisonburg mother of three has been diagnosed with the first known case of the Zika virus in the state. Heather Baker tells media outlets that she received a letter dated Feb. 1 from the Centers for Disease Control and Prevention confirming that she has Zika virus.
Tags: virginia
patient
confirmed
speaks
Fitsi Health Wins 2015 Patient Safety Movement Innovation Award
2016-02-04 11:31:11| Industrial Newsroom - All News for Today
Chicago, IL Fitsi Health, a healthcare innovation firm, announced today the Fitsi bedside caddy received second place, and a $25,000 prize, from the 2015 Patient Safety Movement Innovation Awards. The award was presented at the 4th annual World Patient Safety, Science Technology Summit, which featured keynote...
Tags: health
safety
award
movement
Tru-D SmartUVC Provides Added Safety and Quality to Patient Care at Jupiter Medical Center
2016-01-29 11:31:10| Industrial Newsroom - All News for Today
Unique investment will protect patients and staff with 99.9 percent efficacy JUPITER, Fla. - Jupiter Medical Center recently bolstered its patient and staff safety measures with two Tru-D SmartUVC robots. Tru-D SmartUVC hard at work at Jupiter Medical Center "The Tru-D robots not only allow Jupiter Medical Center...
Tags: center
added
care
quality
FDA OKs Merck hepatitis C drug, adding to patient choices
2016-01-29 02:48:54| Biotech - Topix.net
Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. The combination pill includes the medications elbasvir and grazoprevir, which attack the virus in two different ways.
Tags: drug
adding
patient
choices
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »